Fujita J, Negayama K, Takigawa K, Yamagishi Y, Kubo A, Yamaji Y, Takahara J
First Department of Internal Medicine, Kagawa Medical School, Japan.
J Antimicrob Chemother. 1992 May;29(5):539-46. doi: 10.1093/jac/29.5.539.
The activity of 12 antibiotics, piperacillin, cefazolin, cefotiam, ceftizoxime, latamoxef, ceftazidime, cefuzonam, amikacin, ofloxacin, imipenem, aztreonam and minocycline, against 120 isolates of Pseudomonas aeruginosa was examined. In addition, the efficacy of antibiotics against single-, double-, or triple-drug-resistant isolates of P. aeruginosa were also examined to determine the cross-resistance to each drug. There was cross-resistance between piperacillin, ceftazidime and aztreonam, but amikacin and imipenem remained effective antibiotics, especially as salvage therapy, against isolates resistant to one agent. Results also suggested that piperacillin, ceftazidime or imipenem in combination with amikacin are effective combination regimens against most clinical isolates of P. aeruginosa. Amikacin and imipenem were also suitable antibiotics, especially as salvage therapy, against isolates of P. aeruginosa resistant to two agents. In conclusion, the results provide useful guidelines for choosing an effective treatment against clinical isolates of P. aeruginosa, and for choosing salvage therapy against resistant P. aeruginosa.
检测了12种抗生素(哌拉西林、头孢唑林、头孢替安、头孢唑肟、拉氧头孢、头孢他啶、头孢磺啶、阿米卡星、氧氟沙星、亚胺培南、氨曲南和米诺环素)对120株铜绿假单胞菌的活性。此外,还检测了这些抗生素对单药耐药、双药耐药或三药耐药的铜绿假单胞菌菌株的疗效,以确定对每种药物的交叉耐药性。哌拉西林、头孢他啶和氨曲南之间存在交叉耐药性,但阿米卡星和亚胺培南对耐一种药物的菌株仍然是有效的抗生素,尤其是作为挽救治疗。结果还表明,哌拉西林、头孢他啶或亚胺培南与阿米卡星联合使用是针对大多数临床分离的铜绿假单胞菌的有效联合治疗方案。阿米卡星和亚胺培南也是针对耐两种药物的铜绿假单胞菌菌株的合适抗生素,尤其是作为挽救治疗。总之,这些结果为选择针对临床分离的铜绿假单胞菌的有效治疗方法以及针对耐药铜绿假单胞菌的挽救治疗提供了有用的指导。